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We performed a prospective, randomised trial on106 patients to compare the effects of local
corticosteroid injections with physiotherapy as
advocated by Cyriax in the treatment of tennis elbow.
The main outcome measures were the severity of pain,
pain provoked by resisted dorsiflexion of the wrist,
and patient satisfaction.
At six weeks 22 of 53 patients in the injection group
were free from pain compared with only three in the
physiotherapy group. In the corticosteroid-treated
group 26 patients had no pain on resisted dorsiflexion
of the wrist compared with only three in the
physiotherapy group. Thirty-five patients who had
injections and 14 who had physiotherapy were
satisfied with the outcome of treatment at six weeks.
At the final assessment there were 18 excellent and 18
good results in the corticosteroid group and one
excellent and 12 good results in the physiotherapy
group. There was a significant increase in grip
strength in both groups but those with injections had
a significantly better result.
After one year there were no significant differences
between the two groups. Half of the patients, however,
had received only the initial treatment, 20% had had
combined therapy and 30% had had surgery.
We conclude that at six weeks, treatment with
corticosteroid injections was more effective than
Cyriax physiotherapy and we recommend it because
of its rapid action, reduction of pain and absence of
side-effects.
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Conservative treatment of the tennis elbow syndrome lacks
any scientific basis (Labelle et al 1990). Local corticoste-
roid injections and physiotherapy are common treatments.
Several authors have reported the effectiveness of the
former but after the initial reduction or disappearance of the
symptoms some patients have had recurrence of pain (Free-
land and Gribble 1954; Murley 1954; Quin and Binks
1954; Young, Ward and Henderson 1954; Bailey and Brock
1957; Day, Govindasamy and Patnaik 1978). In many
studies the results of physiotherapy were no better than
those of placebo treatment (Devereaux, Hazleman and Tho-
mas 1985; Lundeberg, Haker and Thomas 1987; Chard and
Hazleman 1988; Lundeberg, Abrahamsson and Haker
1988).
Cyriax (1936, 1982) claimed substantial success for
using local friction in combination with Mills’ manipula-
tions. There have been no comparative studies of these
forms of treatment.
Our aim was to compare the outcome and side-effects of
treatment with local corticosteroids with physiotherapy as
described by Cyriax.
PATIENTS AND METHODS
For one year all patients with tennis elbow referred to the
University Hospital, Maastricht were included in our study.
The criteria for entry were pain on the lateral side of the
elbow, tenderness over the forearm extensor origin, and
pain on the lateral epicondyle during resisted dorsiflexion
of the wrist with the elbow in full extension. Patients were
excluded if they had had a previous operation on the lateral
side of the elbow, or had arthritis or allied conditions,
neurological disorders of the painful extremity, more than
three local corticosteroid injections during the six months
before consultation, and if the same elbow had been treated
before by Cyriax’s methods.
In those with bilateral symptoms only the most painful
arm was included. The patients were randomised into two
groups using sealed numbered envelopes without strata or
blocks. For ethical reasons we did not continue the random-
ised treatment if the results were unsuccessful.
There were 106 patients (59 men and 47 women) with a
mean age of 43 years (SD 9). Physical examination con-
sisted of inspection, measurement of range of movement of
the elbow, and assessment of the pain provoked by resisted
movement and palpation. The mean duration of the symp-
toms was 33 weeks. In 11 patients there was some swelling
around the lateral epicondyle and in seven limited exten-
sion induced by pain on passive or active extension.
Ninety-two patients had been treated by their general prac-
titioner, of whom 34 had been given medication, mostly
non-steroidal anti-inflammatory agents. An average of one
corticosteroid injection had been given (maximum three)
and an average of eight physiotherapy treatments, but not
using the Cyriax technique.
Local corticosteroid injections. We injected 1 ml of triam-
cinolone acetate suspension 1% diluted with 1 ml of lido-
caine 1% into the tendinous origin of the extensor
digitorum and extensor carpi radialis brevis muscles. The
patients were seen two and four weeks after the start of the
treatment and a second or third injection was given if there
were persistent symptoms at the two- or four-week follow-
up. Patients were advised not to use the affected arm for
any activity which provoked pain during the six weeks of
the treatment period.
Physiotherapy according to Cyriax (1936, 1982). Physio-
therapy consisted of deep transverse friction over the exten-
sor origin and Mills’ manipulations. A total of 12
treatments was given over four weeks, followed by another
two weeks of restriction of all painful activities. All physio-
therapists were very experienced in the technique.
At follow-up we assessed the occurrence and severity of
pain, subjective loss of grip strength, time of return to work
and performed provocation tests (resisted movement), local
tenderness, localisation of the point of maximal tenderness
and grip strength (hand dynamometer). All patients had at
least two assessments with the same intervals between the
start of treatment and assessment.
Patients were classified as satisfied, moderately satisfied
or dissatisfied and the results graded according to the
criteria of Verhaar et al (1993) (Table I).
If the treatment had been unsuccessful after six weeks, it
was discontinued and a different method chosen. Con-
servative treatment was considered unsuccessful if the
patient still had moderate or severe symptoms and was
unsatisfied with the outcome. Patients were reviewed again
52 weeks after the start of the treatment.
Operative treatment was considered for patients with
persistent symptoms for more than six months which had
not been alleviated by conservative treatment for more than
three months. The decision to operate, however, depended
also on the individual patient’s functional requirements.
Statistical analysis. Differences between the two treat-
ments groups at 0, 6 and 52 weeks were tested by the chi-
squared test for linear trend and differences in the increase
of grip strength by two-sample t-tests. At 6 and 52 weeks
multiple linear regression was used on the log-transformed
values for grip strength. For the other outcome variables,
multiple polychotomous logistic regression was used to
obtain a more accurate evaluation of the results with cor-
rection for possible imbalances in the randomisation and to
identify other predictors for the outcome at six weeks.
RESULTS
After six weeks of treatment we reviewed 103 patients; two
from the physiotherapy group and one from the injection
group were not examined. Of the injection group 20 had
been treated with one injection, 17 with two, and 16 with
three. At six weeks, the results based on history (Table II)
and physical examination (Table III) showed that the injec-
tion group had improved significantly better than the
physiotherapy group. At one year we found no difference
between the groups. Seventeen patients of the steroid group
and 14 of the physiotherapy group eventually had
operations.
Grip strength. Table IV shows the results. No significant
differences were found. The absolute value of the grip
strength is known to be related to gender, profession,
dominance of the arm, type of sports or hobby, and other
variables. The mean grip strength at 0 weeks was lower in
the local injection group than in the physiotherapy group
and therefore we calculated the increase or decrease in grip
strength at six weeks in the painful compared with the
control arm (Table V). The increase in the grip strength in
the injection group was significantly greater than that in the
physiotherapy group.
Patients’ assessment and result rating. Overall, 48% of
the patients were satisfied with the improvement after six
weeks (Table VI). Satisfaction was lower in the physio-
therapy group (p < 0.001). At six weeks, 49 (47%) had a
good or excellent result. Eighteen of the injection group
and one of the physiotherapy group were completely free
from symptoms.
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Table I. Scoring system for the results of treatment based on the 
criteria of Verhaar et al (1993)
Excellent Complete relief of pain on the lateral epicondyle
Patient satisfied with the result of treatment
No subjective loss of grip strength
No pain provoked by resisted dorsiflexion of
the wrist
Good Occasional slight pain on the lateral epicondyle
after strenuous activities
Patient satisfied with the result of treatment
No or slight subjective loss of grip strength
No pain provoked by resisted dorsiflexion of the
wrist
Fair Discomfort on the lateral epicondyle after
strenuous activities but at a more tolerable level
than before treatment
Patient satisfied or moderately satisfied with the
result of treatment
Slight or moderate subjective loss of grip strength
Slight or moderate pain provoked by resisted
dorsiflexion of the wrist
Poor No decrease of pain on the lateral epicondyle
Patient dissatisfied with the result of treatment
Severe subjective loss of grip strength
Severe pain provoked by resisted dorsiflexion of
the wrist
130 J. A. N. VERHAAR, G. H. I. M. WALENKAMP, H. VAN MAMEREN, A. D. M. KESTER, A. J. VAN DER LINDEN
THE JOURNAL OF BONE AND JOINT SURGERY
Table II. Subjective variables at 0, 6 and 52 weeks for the physiotherapy group  (P) and
for the injection group (I)
0 6 52
P I P I p value* P I
Severity of pain
Absent 0 0 3 22 16 9
Slight 1 2 19 20 <0.001 21 26
Moderate 32 30 22 9 11 14
Severe 20 21 7 1 5 4
Occurrence of pain
Never 0 0 3 22 16 10
Seldom 5 4 15 15 <0.001 16 23
Regularly 25 22 24 12 16 12
Often/continuously 23 27 9 3 5 8
Subjective loss of grip strength
Absent 10 6 13 32 25 26
Slight 11 12 24 13 <0.01 18 21
Moderate 25 28 12 5 9 6
Severe 7 7 2 2 1 0
Resumption of labour
Resumed 4 9 19 21
Still working 14 15 <0.05 8 13
Unable to work 13 9 6 2
Not applicable 20 19 20 17
Missing 2 1
Total 53 53 53 53 53 53
*differences between 0 and 6 weeks
Table III. Results of physical examination at 0, 6 and 52 weeks for the physiotherapy group  (P) and for the
injection group (I)
0 6 52
P I P I p value* P I p value
Resisted dorsiflexion of the wrist
Absent 0 0 5 26 23 16
Slight 9 7 24 17 <0.001 25 32 <0.05
Severe 44 46 22 9 5 5
Resisted dorsiflexion of middle fingers
Absent 12 6 22 37 33 29
Slight 33 39 23 15 <0.001 20 24 <0.05
Severe 8 8 6 0 0 0
Local tenderness
Absent 0 0 4 26 16 14
Slight 15 9 21 14 <0.001 28 30 <0.05
Moderate 25 27 21 11 9 9
Severe 13 17 5 1 0 0
Missing 2 1
Total 53 53 53 53 53 53
*differences between 0 and 6 weeks
Table IV. Mean grip strength (kg ± SD) at 0, 6




0 18.4 ± 9.3 23.5 ± 13.8
6 29.1 ± 15.9 25.6 ± 13.7
52 33.1 ± 13.5 34.5 ± 14.6
Control arm
0 36.3 ± 13.7 37.8 ± 14.0
6 34.5 ± 13.5 37.2 ± 15.2
52 35.9 ± 13.1 36.5 ± 15.7
Table V. Increase (decrease) in grip strength  (kg;
mean ± SD) at 6 and 52 weeks compared with the
initial grip strength for the physiotherapy and the




Physiotherapy 2.3 ± 10.6 11.0 ± 13.8
Injection 10.7 ± 14.9 14.6 ± 13.1
p = 0.0015 p > 0.05
Control arm
Physiotherapy -0.6 ± 8.7 -0.1 ± 10.9
Injection -1.8 ± 5.6 -0.3 ± 6.8
p > 0.05 p > 0.05
Side-effects. One of the 53 patients discontinued physio-
therapy because of severe pain. No side-effects of either
treatment were seen at follow-up after six and 52 weeks.
There were no infections after the injections and no skin
hypopigmentation.
Additional treatments between 6 and 52 weeks. After the
assessment of the results at six weeks several patients
needed additional treatment. At six weeks 27 of the Cyriax
group did not require further treatment but four of these
returned with a recurrence of symptoms; in the injection
group 40 did not require further treatment but 16 returned
because of recurrent symptoms. Three received treatment
with physiotherapy and the other 13 had local corticoste-
roid injections. Thus, six weeks of treatment sufficed in half
of our patients (23 in the physiotherapy group and 24 in the
corticosteroid group).
Statistical analysis of outcome of treatment at 6 and 52
weeks. Multiple linear and logistic regression showed that
treatment was the most important factor determining out-
come at six weeks. Patients from the corticosteroid group
had a better result than those treated by Cyriax’s method. If
the patient had cervical symptoms before the start of
treatment this was likely to be associated with a poor result
from physiotherapy. Local tenderness of the epicondyle
was more likely to persist. If at the first consultation, there
was more pain on resisted dorsiflexion of the middle finger
this was likely to correlate with a better result. No sig-
nificant relationship with other variables was found. A
similar analysis for the outcome of treatment at 52 weeks
showed that there were no predictors of the end result of
treatment.
DISCUSSION
Our results showed that after six weeks of treatment there
was a significant improvement in the entire group of
patients but that corticosteroid injections were better than
the Cyriax physiotherapy regimen. The success rate in the
injection group (69%) was somewhat lower than previously
reported results. Valtonen (1967) reported a success rate of
86% and Hughes and Currey (1969) of 95%. Day et al
(1978) showed that 92% of their patients improved or were
cured with corticosteroid injections. These differences may
be explained by different definitions of success. For that
reason we have attempted to standardise the criteria of
success.
Our results in the physiotherapy group (27%) are also
somewhat lower than the 29% to 53% success rate obtained
by other authors (Hughes and Currey 1969; Devereaux et al
1985). In our study no other method of physiotherapy was
compared with the Cyriax treatment. Our results are sim-
ilar, however, to those of other types of physiotherapy used
by other authors (Devereaux et al 1985; Lundeberg et al
1988; Chard and Hazleman 1989).
None of the outcome variables in our study is free from
the possibility of observer bias. Even grip strength is not
without bias because it is an indirect measure of pain. We
could not blind the study for the patients due to the
differences of treatment. The risk of observer bias would
have been reduced if an independent observer had seen the
patients before and after treatment, but we were unable to
organise this.
Pain may be influenced by many factors and is difficult
to measure. We therefore used grip strength measured with
a hand dynamometer as a more objective indication of the
outcome of treatment. Gripping is mainly carried out by the
forearm flexors. Power grip, however, requires a fixed wrist
joint in 15° of dorsiflexion (van Gemert 1984). This action
of the forearm extensors generates tensile forces at the
common extensor origin, which is painful in tennis elbow.
Thus, grip-strength measures the severity of pain and may
serve as a quantitative measure of the response to treatment
(Goldie 1964; Nirschl 1973; Thurtle, Tyler and Cawley
1984).
After an initially successful six weeks of treatment,
many patients had recurrence of pain, 34% in the cortico-
steroid injection group. Most studies of treatment with
steroid injections with a short follow-up have claimed
excellent results (Hohl 1961; Valtonen 1967; Hughes and
Currey 1969; Clarke and Woodland 1975; Day et al 1978;
Nevelos 1980). At six months, however, all reported a high
recurrence rate, 66% in one group of patients. Thus, corti-
costeroid injections may alleviate the pain in tennis elbow
very well, but may not address the cause.
Many physicians regard tennis elbow as a benign self-
limiting condition, which improves with or without treat-
ment within 8 to 12 months (Cyriax 1936; Quin and Binks
1954; Bailey and Brock 1957). Our study shows that for a
selected group of patients it may be the source of prolonged
pain and persistent impairment of activities for many
months. The duration of symptoms may exceed one year
and the economic consequences for some patients may be
very high. Half of our patients were unable to work when
they were referred. After one year of treatment 9% still
experienced severe pain and 68% had intermittent pain;
only 23% were completely free from pain. Our results are
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Table VI. Patients’ assessment and result rating at 6 and 52
weeks
6 52
P I p value P I p value
Satisfaction
Dissatisfied 26 9 10 10
Moderately 11 8 <0.001 13 17 <0.05
satisfied
Satisfied 14 35 30 26
Result rating
Excellent 1 18 15 12
Good 12 18 <0.001 16 22 <0.05
Moderate 15 10 17 15
Poor 23 6 5 4
Missing 2 1 0 0
comparable with those of Binder and Hazleman (1983);
after one year of treatment 23% of their patients had severe
pain, 57% had intermittent pain and 28% were painfree. It
must be stressed that our patients had been referred by
general practitioners and therefore were only a selection of
all patients with tennis elbow.
The high percentage of patients with symptoms which
persisted for longer than one year is disappointing, but the
severity of symptoms was significantly reduced after one
year of treatment. Many patients with persistent symptoms
considered them not to be severe enough to require further
treatment. In our series 30% of patients had operations
because of persistent symptoms. This figure seems to be
rather high in comparison with other studies in which 5% to
10% of patients were treated operatively (Roles and
Maudsley 1972). Many of these studies, however, were
done in areas in which patients are not obliged to see a
general practitioner before hospital referral. These study
groups therefore comprise an unselected group of patients
with a better prognosis than those referred after failure of
treatment by a general practitioner.
One year after the start of treatment we found no differ-
ences between our groups. At 52 weeks, 50% of the entire
group of patients had received only the initial treatment
prescribed, 30% had been operated upon and 20% had
received combination therapy. This mixing of treatment
groups may be the reason for the lack of differences
between the groups. The initial treatment was not found to
influence the outcome after one year.
If all methods of treatment for a disorder are equally
effective, the procedure of choice should be the one which
is the least invasive, least expensive and most time-efficient
(Coonrad and Hooper 1973). Our study showed that local
corticosteroid injections gave better pain relief in a shorter
time than the Cyriax physiotherapy method. The high
recurrence rate after corticosteroid injections, however,
suggests that the effect is transient and produces only
symptomatic relief. Injections were more time-efficient
than physiotherapy; there were two additional visits to the
outpatient clinic in the injection group compared with 12
visits to the physiotherapy department. No important side-
effects of either method were found.
Because of the reduced number of hospital visits, the
satisfactory pain relief and the lack of side-effects we
prefer corticosteroid injections as treatment in patients in
whom rest alone does not give adequate relief. After six
weeks, corticosteroid injections were found to be more
effective than the Cyriax treatment although their healing
effect is uncertain.
No benefits in any form have been received or will be received from a
commercial party related directly or indirectly to the subject of this
article.
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